Dennis Burton, PhD

Co-chair
Department of Immunology and Microbiology
California Campus



Scripps Research Joint Appointments

Faculty, Graduate Program

Other Joint Appointments

The Ragon Institute of MGH, MIT and Harvard
IAVI Neutralizing Antibody Center, The Scripps Research Institute

Research Focus

Antibodies and Infectious Disease

The perception of man as the easy victor over microbes has changed dramatically in the last two decades. Vaccination has offered protection against a number of viral pathogens, but it is increasingly recognized that the strategies used in the past will not be successful against all viruses. We are focused on developing rational vaccine strategies, particularly against HIV and particularly using an approach termed “Reverse Vaccinology 2.0”. In this approach, broadly neutralizing antibodies isolated from natural HIV infection are investigated in interaction with their sole viral target, the HIV Envelope, and the data used to guide immunogen design and immunization strategies. Immunogens are then evaluated in detail in animal models and the results used to iteratively improve immunogens as we move toward an HIV vaccine suitable to protect humans.


Education

Ph.D. (Physical Biochemistry), Lund University, 1978
B.A. (Chemistry), University of Oxford, 1974

Professional Experience

2015-2017 Chairman, Immunology and Microbial Science (IMS), Scripps Research
1991-2017 Professor, Immunology and Microbial Science (IMS), Scripps Research
2015-2015 Distinguished Lecturer, The American Association of Immunologists
-2012 Professor (Joint Appointment), Molecular Biology, Scripps Research
1990-1991 Personal Chair, The University of Sheffield
1989-1991 Visiting Member, Research Institute of Scripps Clinic
1985-1991 Jenner Fellow, Lister Institute of Preventive Medicine
1987-1990 Senior Lecturer in Biochemistry, The University of Sheffield
1981-1987 Lecturer in Biochemistry, The University of Sheffield
1980-1981 Junior Research Fellow, Wolfson College, University of Oxford
1979-1981 Medical Research Council Training Fellowship, University of Oxford

Selected References

All Publications

Zhou, T., Zheng, A., Baxa, U., Chuang, G. Y., Georgiev, I. S., Kong, R., O'Dell, S., Shahzad-Ul-Hussan, S., Shen, C. H., Tsybovsky, Y., Bailer, R. T., Gift, S. K., et al. A neutralizing antibody recognizing primarily N-linked glycan targets the silent face of the HIV envelope. (2018). Immunity, 48(3), 500-513.

Cao, L. W., Pauthner, M., Andrabi, R., Rantalainen, K., Berndsen, Z., Diedrich, J. K., Menis, S., Sok, D., Bastidas, R., Park, S. K. R., Delahunty, C. M., He, L., et al. Differential processing of HIV envelope glycans on the virus and soluble recombinant trimer. (2018). Nature Communications, 9. PMCID: PMC6135743.

Bianchi, M., Turner, H. L., Nogal, B., Cottrell, C. A., Oyen, D., Pauthner, M., Bastidas, R., Nedellec, R., McCoy, L. E., Wilson, I. A., Burton, D. R., Ward, A. B., et al. Electron-microscopy-based epitope mapping defines specificities of polyclonal antibodies elicited during HIV-1 BG505 envelope trimer immunization. (2018). Immunity, 49(2), 288-300. PMCID: PMC6104742.

Magnani, D. M., Rogers, T. F., Maness, N. J., Grubaugh, N. D., Beutler, N., Bailey, V. K., Gonzalez-Nieto, L., Gutman, M. J., Pedreno-Lopez, N., Kwal, J. M., Ricciardi, M. J., Myers, T. A., et al. Fetal demise and failed antibody therapy during Zika virus infection of pregnant macaques. (2018). Nature Communications, 9. PMCID: PMC5915455.

Cao, L., Diedrich, J. K., Ma, Y., Wang, N., Pauthner, M., Park, S. K. R., Delahunty, C. M., McLellan, J. S., Burton, D. R., Yates III, J. R. & Paulson, J. C. Global site-specific analysis of glycoprotein N-glycan processing. (2018). Nature Protocols, 13(6), 1196-1212. PMCID: PMC5941933.

Martins, M. A., Tully, D. C., Pedreno-Lopez, N., von Bredow, B., Pauthner, M. G., Shin, Y. C., Yuan, M. L., Lima, N. S., Bean, D. J., Gonzalez-Nieto, L., Domingues, A., Gutman, M. J., et al. Mamu-B*17(+) rhesus macaques vaccinated with env, vif, and nef manifest early control of SIVmac239 replication. (2018). Journal of Virology, 92(16), e00690-18. PMCID: PMC6069176.

Walker, L. M. & Burton, D. R. Passive immunotherapy of viral infections: 'super-antibodies' enter the fray. (2018). Nature Reviews Immunology, 18(5), 297-308. PMCID: PMC5918154.

Wagh, K., Seaman, M. S., Zingg, M., Fitzsimons, T., Barouch, D. H., Burton, D. R., Connore, M., Ho, D. D., Mascola, J. R., Nussenzweig, M. C., Ravetch, J., Gautam, R., et al. Potential of conventional & bispecific broadly neutralizing antibodies for prevention of HIV-1 subtype A, C & D infections. (2018). PLoS Pathogens, 14. PMCID: PMC5854441.

Sok, D. & Burton, D. R. Recent progress in broadly neutralizing antibodies to HIV. (2018). Nature Immunology, 19(11), 1179-1188.

Andrabi, R., Bhiman, J. N. & Burton, D. R. Strategies for a multi-stage neutralizing antibody-based HIV vaccine. (2018). Current Opinion in Immunology, 53, 143. PMCID: PMC6141341.